Cargando…

Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation

We describe here two novel antibody-drug conjugates loaded with the HDAC inhibitor ST7612AA1 (IC(50) equal to 0.07 μM on NCI-H460 cells), a thiol-based molecule with a moderate toxicity in vivo. Two payloads were prepared using cleavable and non-cleavable linkers. After anchoring to cetuximab throug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cini, Elena, Faltoni, Valentina, Petricci, Elena, Taddei, Maurizio, Salvini, Laura, Giannini, Giuseppe, Vesci, Loredana, Milazzo, Ferdinando Maria, Anastasi, Anna Maria, Battistuzzi, Gianfranco, De Santis, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144071/ https://www.ncbi.nlm.nih.gov/pubmed/30288233 http://dx.doi.org/10.1039/c7sc05266a

Ejemplares similares

ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1
por: Milazzo, Ferdinando Maria, et al.
Publicado: (2020)

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor
por: Vesci, Loredana, et al.
Publicado: (2014)

AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies
por: Milazzo, Ferdinando Maria, et al.
Publicado: (2017)

Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical  Thioacetic Acid Addition
por: Battistuzzi, Gianfranco, et al.
Publicado: (2016)

Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
por: VESCI, LOREDANA, et al.
Publicado: (2014)

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
por: Vesci, Loredana, et al.
Publicado: (2015)

ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023)

Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
por: Tassone, Giusy, et al.
Publicado: (2022)

Site-Specific Antibody Conjugation for ADC and Beyond
por: Zhou, Qun
Publicado: (2017)

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
por: Minenkova, Olga, et al.
Publicado: (2022)

Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
por: Yao, Houzong, et al.
Publicado: (2016)

Potential of antibody–drug conjugates (ADCs) for cancer therapy
por: Marei, Hany E., et al.
Publicado: (2022)

Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2021)

New antibody-drug conjugates (ADCs) in breast cancer—an overview of ADCs recently approved and in later stages of development
por: Koster, Kira-Lee, et al.
Publicado: (2022)

TOOLBOX: Strep-Tagged nano-assemblies of antibody-drug-conjugates (ADC) for modular and conditional cancer drugging
por: Tremante, Elisa, et al.
Publicado: (2021)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
por: Janthur, Wolf-Dieter, et al.
Publicado: (2012)

Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)
por: Mantaj, Julia, et al.
Publicado: (2016)

Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies
por: Kang, Xiuhua, et al.
Publicado: (2018)

Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs)
por: Mahmood, Iftekhar
Publicado: (2021)

Interspecies Scaling of Antibody–Drug Conjugates (ADC) for the Prediction of Human Clearance
por: Mahmood, Iftekhar
Publicado: (2021)

Characterization and in vitro data of antibody drug conjugates (ADCs) derived from heterotrifunctional linker designed for the site-specific preparation of dual ADCs
por: Kumar, Amit, et al.
Publicado: (2018)

Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
por: Hammood, Manar, et al.
Publicado: (2021)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?
por: Deonarain, Mahendra P., et al.
Publicado: (2018)

Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
por: Lambert, John M., et al.
Publicado: (2017)

Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
por: McNamara, Blair, et al.
Publicado: (2023)

Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells
por: Chiarenza, Alessandra, et al.
Publicado: (2016)

An Intramolecular Hydroaminomethylation-Based Approach to Pyrrolizidine Alkaloids under Microwave-Assisted Heating
por: Petricci, Elena, et al.
Publicado: (2022)

Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
por: Nguyen, Toan D., et al.
Publicado: (2023)

New classes of potent heparanase inhibitors from ligand-based virtual screening
por: Pala, Daniele, et al.
Publicado: (2020)

Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism
por: Tumey, L. Nathan, et al.
Publicado: (2016)

Kinetic studies and CFD-based reaction modeling for insights into the scalability of ADC conjugation reactions
por: Weggen, Jan Tobias, et al.
Publicado: (2023)

Synthesis of 2-Substitued Indoles via Pd-Catalysed Cyclization in an Aqueous Micellar Medium
por: Siciliano, Sofia, et al.
Publicado: (2021)

Those ADCs
Publicado: (1971)

Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance
por: VESCI, LOREDANA, et al.
Publicado: (2015)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Corrigendum: Kinetic studies and CFD-based reaction modeling for insights into the scalability of ADC conjugation reactions
por: Weggen, Jan Tobias, et al.
Publicado: (2023)

Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADC
por: Figueroa, Isabel, et al.
Publicado: (2018)

ADC : analog-to-digital converter reference manual.

Cannot write session to /tmp/vufind_sessions/sess_i3iu12nl45lmj2e536q2t9okat